What Does the 2025 Research Say About GLP-1s and Psoriatic Arthritis
Appetite can become very low during titration
Microdosing is considered off-label use, or prescribing an approved drug for an unapproved use, which doctors are allowed to do if they deem it medically appropriate
Finally A GLP-1 meal plan Guide That Actually Helps If youre taking Ozempic, Wegovy, Mounjaro, Zepbound, or another GLP-1 medication, you already know its a game-changer but it can also be incredibly confusing
There is only one clinical trial for lixisenatide in PD, assessing its efficacy in slowing motor disability progression in early-stage patients over 12 months, followed by a 2-month washout period
On August 1, 2024, North Carolina Medicaid launched coverage for glucagon-like peptide 1 (GLP-1s) drugs for weight loss despite the State Health Plan (SHP) ending coverage on April 1, 2024